The BRI Blog
For recent medical community news and insights, engage with our recent posts below.
Sally Pipes: “Cancer Breakthroughs Threatened by D.C.’s Price Controls”
February 9, 2026 by bmew
Decades of innovation have given us powerful new tools for treating cancer, and saved millions of lives. If we want continued progress against cancer, Congress must reject aggressive price controls.
Sally Pipes: “House GOP Must Promote Commonsense Health Care Reform”
February 6, 2026 by bmew
As Democrats campaign once again to extend the COVID-19 enhanced Obamacare subsidies, Republicans have an opportunity to enact legislation that will actually result in more affordable care.
Sally Pipes: “Open, Competitive Market Will Make Trump’s Health Plan Great”
February 3, 2026 by bmew
Market forces keep drug prices in check, foster innovation, preserve quality, and expand availability. Codifying foreign price controls, however, will move us backward.
Sally Pipes: “CMS Officials Are Undermining Trump’s Push For Affordable Drugs”
February 2, 2026 by bmew
Fierce competition for market share leads to massive discounting. In 2024 alone, biosimilars saved the U.S. healthcare system an estimated $20 million. Government price controls, however, impede market forces–and innovation.
Sally Pipes: “Sorry, But Single-Payer Won’t Fix American Health Care”
February 2, 2026 by bmew
The American health care system in its current form is not perfect. But Trading our system for one that routinely delays care, rations treatment and leaves patients dying in hallways would be a grave mistake.
Sally Pipes: “Proposed Patent Tax Offers a Dangerous ‘Solution’ to a Non-Existent Problem”
January 27, 2026 by bmew